AstraZeneca faces lawsuit over promotion of Nexium
LOS ANGELES: Members of the Prescription Access Litigation Process (PAL), a watchdog group for drug pricing issues, have sued AstraZeneca over the way it promoted heartburn drug Nexium.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>